Several important breakthroughs have been reported recently, especially with adult brain tumors, where a transient yet complete remission in a patient with disseminated glioblastoma (GBM) treated with IL13Rα2-specific CAR T cells has been reported [17]. The gene discussed is IL13RA2; the disease is glioblastoma.